CPT code 83529 represents a laboratory chemistry test that quantifies interleukin‑6 (IL‑6) in serum or plasma, typically performed using immunoassay methods. IL‑6 is a key inflammatory cytokine, and measuring its level has clinical relevance in diagnosing and monitoring inflammatory states related to infection, autoimmune disease, cardiovascular conditions, and some malignancies. Nationally, use of IL‑6 testing has grown as clinicians seek biomarkers to guide care in complex inflammatory and infectious presentations.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for the assay, common sites of service, and what the code covers for billing purposes. The publication summarizes typical service lines, payer coverage considerations, and operational benchmarks where available. It also outlines common reporting formats and coding implications for laboratories and billing teams.

This summary prepares clinical laboratory directors, revenue cycle managers, and policy analysts to understand the role of CPT code 83529 in care pathways and payer interactions, and to locate more detailed benchmarks and policy updates in the full report. Data not available in the input.